AstraZeneca PLC (AZN)
NYSE·Healthcare·Drug Manufacturers - General
$187.05
-0.25%
Mkt Cap $311.13B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $15.44B | $15.50B | +0.39% | $2.18 | $2.12 | -2.75% | — | — |
| Q4 2025 Nov 6, 2025 | $15.42B | $15.19B | -1.51% | $2.29 | $2.38 | +3.93% | — | — |
| Q3 2025 Jul 29, 2025 | $14.76B | $14.46B | -2.08% | $2.16 | $2.18 | +0.93% | — | — |
| Q2 2025 Apr 29, 2025 | $14.06B | $13.59B | -3.34% | $2.25 | $2.48 | +10.22% | — | — |
| Q1 2025 Feb 6, 2025 | $13.34B | $14.89B | +11.60% | $2.07 | $2.10 | +1.45% | — | — |
| Q4 2024 Nov 12, 2024 | $13.09B | $13.56B | +3.65% | $2.04 | $2.08 | +1.96% | — | — |
| Q3 2024 Jul 25, 2024 | $13.08B | $12.94B | -1.09% | $1.97 | $1.98 | +0.51% | — | — |
| Q2 2024 Apr 25, 2024 | $11.80B | $12.68B | +7.47% | $1.91 | $2.06 | +7.85% | — | — |
| Q1 2024 Feb 8, 2024 | $12.08B | $12.02B | -0.46% | $1.46 | $1.46 | +0.00% | — | — |
| Q4 2023 Nov 9, 2023 | $11.55B | $11.49B | -0.52% | $0.84 | $1.74 | +106.41% | — | — |
| Q3 2023 Jul 28, 2023 | $11.01B | $11.42B | +3.67% | $0.99 | $2.16 | +118.62% | — | — |
| Q2 2023 Apr 27, 2023 | $10.60B | $10.88B | +2.59% | $0.85 | $1.92 | +124.82% | — | — |
| Q1 2023 Feb 9, 2023 | $11.25B | $11.21B | -0.38% | $0.67 | $1.38 | +105.36% | — | — |
| Q4 2022 Nov 10, 2022 | $10.79B | $10.98B | +1.79% | $0.76 | $1.68 | +121.64% | — | — |
| Q3 2022 Jul 29, 2022 | $10.45B | $10.77B | +3.03% | $0.78 | $1.72 | +119.67% | — | — |
| Q2 2022 Apr 29, 2022 | $10.99B | $11.39B | +3.63% | $1.72 | $1.90 | +10.47% | — | — |
| Q1 2022 Feb 10, 2022 | $11.16B | $12.01B | +7.66% | $1.54 | $1.68 | +9.09% | — | — |
| Q4 2021 Nov 12, 2021 | $11.28B | $9.87B | -12.50% | $1.26 | $1.08 | -14.29% | — | — |
| Q3 2021 Jul 29, 2021 | $7.59B | $8.22B | +8.36% | $0.90 | $0.90 | +0.00% | — | — |
| Q2 2021 Apr 30, 2021 | $6.64B | $7.32B | +10.29% | $1.42 | $1.62 | +14.08% | — | — |